Immunogenicity and safety in healthy adults of full dose versus half doses of COVID-19 vaccine (ChAdOx1-S or BNT162b2) or full-dose CoronaVac administered as a booster dose after priming with CoronaVac: a randomised, observer-masked, controlled trial in Indonesia
- Resource Type
- Source
- The Lancet Infectious Diseases. 23:545-555
- Subject
Infectious Diseases - Language
- ISSN
- 1473-3099